4//SEC Filing
GUSTAFSON MARK 4
Accession 0001214659-22-003987
CIK 0001677077other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 7:12 PM ET
Size
7.1 KB
Accession
0001214659-22-003987
Insider Transaction Report
Form 4
GUSTAFSON MARK
Director
Transactions
- Exercise/Conversion
Common Stock
2022-03-15+50,000→ 80,000 total - Exercise/Conversion
Restricted Stock Grant
2022-03-15−50,000→ 0 totalExp: 2022-03-15→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]Represents the vesting of restricted stock.
- [F2]Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc.
- [F3]2,778 and 47,222 restricted shares previously vested on September 13, 2021 and October 13, 2021, respectively, with the final 50,000 shares of restricted stock vesting on March 15, 2022.
Documents
Issuer
Alzamend Neuro, Inc.
CIK 0001677077
Entity typeother
Related Parties
1- filerCIK 0001303996
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 7:12 PM ET
- Size
- 7.1 KB